Evidence map›Paper›PMID 35866738›Full record

ArticleBiomedica : revista del Instituto Nacional de Salud2022

Molecular characterization of colorectal cancer patients

Carlos Humberto Afanador, Katherine Andrea Palacio, Luis Fernando Isaza, Enoc Ahumada, Carlos Mauricio Ocampo, Carlos Mario Muñetón

Open access · diamondAbstract read
In one paragraph

Article in Biomedica : revista del Instituto Nacional de Salud, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Cancers · 2024
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Carlos Humberto AfanadorUnidad de Genética Médica, Departamento de Pediatría, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia. biomedica@ins.gov.co.
Katherine Andrea PalacioUnidad de Genética Médica, Departamento de Pediatría, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia. biomedica@ins.gov.co.
Luis Fernando IsazaDepartamento de Cirugía, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia; Hospital Fundación San Vicente de Paúl, Medellín, Colombia; Clínica Las Vegas, Medellín, Colombia. biomedica@ins.gov.co.
Enoc AhumadaDepartamento de Patología, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia. biomedica@ins.gov.co.
Carlos Mauricio OcampoDepartamento de Cirugía, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia. biomedica@ins.gov.co.
Carlos Mario MuñetónUnidad de Genética Médica, Departamento de Pediatría, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia. carlos.muneton@udea.edu.co.
Universidad de Antioquia · COHospital Universitario de San Vicente Fundación · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Colorectal cancer has a high incidence in the world population. Different molecular pathways, such as chromosomal instability, microsatellite instability, and epigenetics are involved in its development. Objective: To perform molecular characterization in 44 individuals with sporadic colorectal cancer. Materials and methods: We conducted mutation analyses of the APC, KRAS, TP53 y BRAF genes using Sanger sequencing techniques; microsatellite instability was determined by capillary electrophoresis with five STR genetic markers while the methylation status of the MHL1 promotor gene was analyzed using methylation-specific PCR. Results: APC, KRAS, and TP53 genes mutation frequency was 18.1%, 25%, and 4.5%, respectively; the somatic mutations detected were located more frequently in the right colon. The frequency of microsatellite instability was 27.2% and 73.1% of the tumors had the MHL1 gene methylated while 91.6% of microsatellite instability-positive tumors had the methylated MLH1 gene. The mutation profile of microsatellite stability tumors APC, KRAS, and TP53 genes was more frequent than in the microsatellite instability-positive tumors. The methylation of the MLH1 gene was the most predominant molecular alteration. Conclusions: We identified molecular alterations in different genetic pathways of the colorectal cancer patients evaluated, which are common in the carcinogenesis of this cancer. These patients showed a different mutational profile compared to other populations. Our findings confirm the molecular heterogeneity described in the development of colorectal cancer.

Indexed as

Colorectal NeoplasmsMicrosatellite InstabilityHumansProto-Oncogene Proteins p21(ras)Retrospective StudiesProto-Oncogene Proteins p21(ras)epigenómicagenes supresores de tumorheterogeneidad genéticainestabilidad de microsatélitesneoplasias colorrectales/genéticaoncogenes

Identifiers

PMID35866738
PMCPMC9414253
OpenAlexW4285103174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.